| Literature DB >> 18981818 |
Yee-Jin Jeon1, Ha-Young Won, Mi-Young Moon, Won-Ho Choi, Chun-Ho Chang, Jae-Yong Lee, Jaebong Kim, Sung-Chan Kim, Yong-Sun Kim, Jae-Bong Park.
Abstract
Amyloid-beta (Abeta) is one of the main factors to cause Alzheimer's disease. Although fibrillar Abeta (fAbeta) activates microglial cells that release toxic compounds to induce partial neuronal death, the mechanism of interaction between Abeta and microglia remains unclear. Therefore, we examined the interaction of microglial cells (BV2) and fAbeta on a gelatin-precoated plate. The binding was markedly enhanced by RhoA inactivation using Tat-C3, dominant negative RhoA, and si-RhoA. To identify the receptor for fAbeta, we tested various antibodies to mask receptors. Among them, anti-beta2-integrin antibody mostly suppressed cell binding to fAbeta. The incremental binding of cells induced by RhoA inhibition was also blocked by addition of anti-beta2-integrin antibody. These results suggest that RhoA inhibition stimulates beta2-integrin-mediated cell interaction to fAbeta.Entities:
Mesh:
Substances:
Year: 2008 PMID: 18981818 DOI: 10.1097/WNR.0b013e3283140f10
Source DB: PubMed Journal: Neuroreport ISSN: 0959-4965 Impact factor: 1.837